Department of Obstetrics and Gynecology, International Peace Maternity and Child Health Hospital of the China Welfare Institute Affiliated to Shanghai Jiao Tong University, Shanghai 200030, PR China.
Oncol Rep. 2013 Jun;29(6):2297-302. doi: 10.3892/or.2013.2400. Epub 2013 Apr 10.
Increasing evidence suggests that miR‑205 is frequently dysregulated in many types of human cancers, suggesting its important roles in the initiation and progression of cancer. However, the functions of miR‑205 in human endometrial endometrioid carcinoma (EEC) are still unknown. In this study, we investigated the expression of miR‑205 in both normal endometrium and EEC tissues using TaqMan PCR. Compared to normal tissues, miR‑205 was significantly upregulated in EEC (P<0.001). After transfection of miR‑205 inhibitors into Ishikawa cells (or transfection of miR‑205 mimics into AN3CA cells), we demonstrated that the cellular proliferation, migration and invasion properties were negatively regulated by miR‑205. Moreover, by combination of microRNA target prediction algorithms and luciferase reporter system, we identified estrogen-related receptor‑γ (ESRRG) as a target of miR‑205. In conclusion, we demonstrated frequent upregulation of miR‑205 in EEC. In gain‑of‑function and loss‑of‑function assays, inhibition of miR‑205 reduced cellular proliferation, migration and invasion; vice versa, increased levels of miR‑205 led to upregulated cellular proliferation, migration and invasion. Nonetheless, we identified the ESRRG gene to be a novel target, which could be helpful to elucidate mechanisms underlying the tumorigenesis of EEC.
越来越多的证据表明,miR-205 在多种人类癌症中经常失调,表明其在癌症的发生和发展中具有重要作用。然而,miR-205 在人子宫内膜样腺癌(EEC)中的功能仍不清楚。在本研究中,我们使用 TaqMan PCR 检测了 miR-205 在正常子宫内膜和 EEC 组织中的表达。与正常组织相比,miR-205 在 EEC 中显著上调(P<0.001)。用 miR-205 抑制剂转染 Ishikawa 细胞(或用 miR-205 模拟物转染 AN3CA 细胞)后,我们证明 miR-205 可负调控细胞增殖、迁移和侵袭特性。此外,通过结合 microRNA 靶标预测算法和荧光素酶报告系统,我们鉴定出雌激素相关受体γ(ESRRG)是 miR-205 的靶标。总之,我们证实了 miR-205 在 EEC 中频繁上调。在功能获得和功能丧失实验中,抑制 miR-205 降低了细胞增殖、迁移和侵袭;反之,增加 miR-205 的水平导致细胞增殖、迁移和侵袭增加。尽管如此,我们鉴定出 ESRRG 基因是一个新的靶标,这有助于阐明 EEC 肿瘤发生的机制。